Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junqi Niu

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
Journal of Nanobiotechnology|June 5, 2024
Exosomes target HBV-host interactions to remodel the hepatic immune microenvironmentXiaojing Wu, Junqi Niu, Ying Shi
Biomed Research International|September 19, 2019
Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver InjuryXu Li, Pujun Gao, Junqi Niu
The Journal of Arthroplasty|February 9, 2024
Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/OsteoprotegerinJunqi Niu, Fanggang Bi, Qing Tian, et al.
Medicine|April 28, 2019
Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinomaXu Liu, Jing Meng, Hongqin Xu, et al.
Molecular Biology Reports|March 17, 2021
Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanismsHeming Ma, Xu Liu, Mingyuan Zhang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 18, 2019
The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary CholangitisXu Liu, Hongqin Xu, Mengru Zhan, et al.
International Immunopharmacology|February 9, 2025
Activation of immune checkpoint OX40 inhibits HBV replication in a mouse modelMengru Zhan, Shaoling Zhong, Junqi Niu, et al.
Gastroenterology Research and Practice|August 24, 2017
Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in ChinaTianyi Ren, Huan Wang, Ruihong Wu, et al.
Molecular Immunology|August 27, 2023
FcγRIIB expression increases during primary biliary cholangitisXiuzhu Gao, Heming Ma, Junqi Niu, et al.
Stem Cell Research & Therapy|May 16, 2022
The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trialsYuwei Liu, Yutong Dong, Xiaojing Wu, et al.
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
Journal of Nanobiotechnology|June 5, 2024
Exosomes target HBV-host interactions to remodel the hepatic immune microenvironmentXiaojing Wu, Junqi Niu, Ying Shi
Biomed Research International|September 19, 2019
Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver InjuryXu Li, Pujun Gao, Junqi Niu
The Journal of Arthroplasty|February 9, 2024
Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/OsteoprotegerinJunqi Niu, Fanggang Bi, Qing Tian, et al.
Medicine|April 28, 2019
Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinomaXu Liu, Jing Meng, Hongqin Xu, et al.
Molecular Biology Reports|March 17, 2021
Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanismsHeming Ma, Xu Liu, Mingyuan Zhang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 18, 2019
The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary CholangitisXu Liu, Hongqin Xu, Mengru Zhan, et al.
International Immunopharmacology|February 9, 2025
Activation of immune checkpoint OX40 inhibits HBV replication in a mouse modelMengru Zhan, Shaoling Zhong, Junqi Niu, et al.
Gastroenterology Research and Practice|August 24, 2017
Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in ChinaTianyi Ren, Huan Wang, Ruihong Wu, et al.
Molecular Immunology|August 27, 2023
FcγRIIB expression increases during primary biliary cholangitisXiuzhu Gao, Heming Ma, Junqi Niu, et al.
Stem Cell Research & Therapy|May 16, 2022
The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trialsYuwei Liu, Yutong Dong, Xiaojing Wu, et al.
Pageof 28